Capital Flow Monitor · Sponsors · CIK 1938571
ADAPTIN BIO, INC.
3540 TORINGDON WAY, CHARLOTTE, NC, 28277 · (888) 609-1498
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$4.0M
Sold
$1.9M
% sold
47.8%
Investors
19
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | D/A ·current | 506(b) | $4.0M | $1.9M | 47.8% | 19 | EDGAR ↗ |
| 2026-03-23 | D/A | 506(b) | $4.0M | $1.7M | 41.3% | 13 | EDGAR ↗ |
| 2026-02-20 | D/A | 506(b) | $4.0M | $1.3M | 32.4% | 10 | EDGAR ↗ |
| 2026-01-05 | D | 506(b) | $4.0M | $1.0M | 25.0% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Michael Roberts — Executive Officer / Director, Charlotte, NC
- Patrick Gallagher — Director, Charlotte, NC
- J. Nick Riehle — Director, Charlotte, NC
- Anthony Zook — Director, Charlotte, NC
- L. Arthur Hewitt — Executive Officer, Charlotte, NC
- Timothy Maness — Executive Officer, Charlotte, NC
- Simon Pedder — Executive Officer / Director, Charlotte, NC
Placement agents
- Laidlaw & Company (uk) Ltd · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.